USDA's watchdog, the Office of the Inspector General, is investigating Neuralink, a medical device company that is developing brain implant...

In May, CanSino became the first globally to publish a full scientific study on its early human trials, an important step because it allows...

Isro has kickstarted the process of selecting experiments that could be performed in the Low Earth Orbit.

"The big shift is that India is moving from the periphery to the core of such mega global science projects", says RA Mashelkar former direc...

Here is a list of top stocks that are likely to be in focus today.

The novel drug known as Tildrakizumab is currently under review by the US FDA and the European Medicines Agency (EMA). The value of the con...

While the market opportunities to sell brands appear optimistic, that road is less treaded by Indian companies and obvious challenges can l...

Such homecomings are driven partly by family compulsions, but now it is a flurry of incentives by the govt that has helped scientists reloc...

Gopalakrishnan has funded a stem cell-centred multidisciplinary programme on mental diseases and blood disorders, by providing Rs 6 crore.

In 2014, Apple and Facebook became the first major employers to offer female employees coverage to freeze their eggs without a medical reas...

A Southern California mite has set a new record as world's fastest land animal and the little creature can run 20 times faster than a cheet...

As students demand quality learning with a wider choice of subjects & an assurance of employability, pvt universities are promising that ch...

It is not just Big Pharma that has to prepare for life after the 'patent cliff'' patent expiries on a slew of blockbuster drugs.